Mystery Alzheimer’s Drug May Yield Advance for Pfizer (Update1) (Bloomberg)

Feb. 2 (Bloomberg) — Doctors may learn next month that Dimebon, a 27-year-old hay fever treatment and one of the most mysterious compounds yet tried to fight dementia, is poised to become their newest and perhaps best weapon against Alzheimer’s.

Read the rest here:
Mystery Alzheimer’s Drug May Yield Advance for Pfizer (Update1) (Bloomberg)

Tags: mysterious-compounds, most, hay-fever, fight-dementia, become-their, newest-and, newest

Related posts:

  1. Mystery Medicine for Alzheimer’s May Yield Advance for Pfizer (BusinessWeek)
  2. Alzheimer Results From J&J May Be Pushed Back to 2012 (Update1) (Bloomberg)
  3. Alzheimer Drug Test Result From J&J May Be Pushed Back to 2012 (Bloomberg)
  4. Pfizer Alzheimer’s drug fails in study (USA Today)
  5. Pfizer Alzheimer’s disease drug fails in study (AP via Yahoo! News)

Leave a Reply